Noden Pharma
Dublin
About Noden Pharma
Noden Pharma is a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a range of therapeutic areas. Noden Pharma DAC holds exclusive worldwide rights to manufacture, market and sell Tekturna® and Tekturna HCT® (or Rasilez® and Rasilez HTC® outside of the United States), which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $107.0M
- Funding stage: M&A
- Last round: Series Unknown (Sep 2020)
- Website: nodenpharma.com
- Phone: +353 1 6778458
Industries & Categories
Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/noden-pharma-114778 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.